The clearance is a step forward in AstraZeneca and Daiichi Sankyo’s plan to position antibody-drug conjugates like Enhertu ...

The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...

Astra is due to pay Daiichi US$175 million in milestones after the US approval, the companies said. Enhertu is cleared in the ...

The U.S. Food and Drug Administration has officially banned red dye — called Red 3, or Erythrosine — from foods, dietary ...

Zentalis Pharmaceuticals said it would cut 40% of its workforce as part of a restructuring to support the late-stage development of its cancer-drug azenosertib.

Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer ...

Studies going back decades have shown a potential link between artificial food dyes and attention deficit hyperactivity ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

During Donald Trump's draconian first-week rollbacks, cancer research and other crucial medical projects have been paused ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

The synthetic additive found in thousands of food products will now be phased out by 2027, but advocates say the agency's ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...